Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. McCall, WV
   Electroconvulsive thera in the era of modern psychopharmacology
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   W.V. McCall, "Electroconvulsive thera in the era of modern psychopharmacology", IN J NEUROP, 4(3), 2001, pp. 315-324
2. Segal, J; Isaacs, MD; Berk, M
   Neuroleptic malignant syndrome: Possible induction by olanzapine in a casewith relapsing catatonia
   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
   
   J. Segal et al., "Neuroleptic malignant syndrome: Possible induction by olanzapine in a casewith relapsing catatonia", INT J PSYC, 5(3), 2001, pp. 211-213
3. Malur, C; Francis, A
   Emergence of catatonia during ECT
   JOURNAL OF ECT
   
   C. Malur e A. Francis, "Emergence of catatonia during ECT", J ECT, 17(3), 2001, pp. 201-204
4. Aziz, M; Maixner, DF; DeQuardo, J; Aldridge, A; Tandon, R
   ECT and mental retardation: A review and case reports
   JOURNAL OF ECT
   
   M. Aziz et al., "ECT and mental retardation: A review and case reports", J ECT, 17(2), 2001, pp. 149-152
5. Malur, C; Pasol, E; Francis, A
   ECT for prolonged catatonia
   JOURNAL OF ECT
   
   C. Malur et al., "ECT for prolonged catatonia", J ECT, 17(1), 2001, pp. 55-59
6. Reeves, RR; Mack, JE; Torres, RA
   Neuroleptic malignant syndrome during a change from haloperidol to risperidone
   ANNALS OF PHARMACOTHERAPY
   
   R.R. Reeves et al., "Neuroleptic malignant syndrome during a change from haloperidol to risperidone", ANN PHARMAC, 35(6), 2001, pp. 698-701
7. Shiloh, R; Weizman, A; Epstein, Y; Rosenberg, SL; Valevski, A; Dorfman-Etrog, P; Wiezer, N; Katz, N; Munitz, H; Hermesh, H
   Abnormal thermoregulation in drug-free male schizophrenia patients
   EUROPEAN NEUROPSYCHOPHARMACOLOGY
   
   R. Shiloh et al., "Abnormal thermoregulation in drug-free male schizophrenia patients", EUR NEUROPS, 11(4), 2001, pp. 285-288
8. Hermesh, H; Manor, I; Shiloh, R; Weizman, R; Munitz, H
   Absence of myoglobinuria in acute psychotic patients with marked elevationin serum creatine phosphokinase level
   EUROPEAN NEUROPSYCHOPHARMACOLOGY
   
   H. Hermesh et al., "Absence of myoglobinuria in acute psychotic patients with marked elevationin serum creatine phosphokinase level", EUR NEUROPS, 11(2), 2001, pp. 111-115
9. Oberg, K
   Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
   ANNALS OF ONCOLOGY
   
   K. Oberg, "Chemotherapy and biotherapy in the treatment of neuroendocrine tumours", ANN ONCOL, 12, 2001, pp. S111-S114
10. Arnaout, MS; Antun, FP; Ashkar, K
    Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    M.S. Arnaout et al., "Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia", HUM PSYCHOP, 16(3), 2001, pp. 279-281
11. Muqit, MMK; Rakshi, JS; Shakir, RA; Larner, AJ
    Catatonia or abulia? A difficult differential diagnosis
    MOVEMENT DISORDERS
    
    M.M.K. Muqit et al., "Catatonia or abulia? A difficult differential diagnosis", MOVEMENT D, 16(2), 2001, pp. 360-362
12. Kalant, H
    The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
    CANADIAN MEDICAL ASSOCIATION JOURNAL
    
    H. Kalant, "The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs", CAN MED A J, 165(7), 2001, pp. 917-928
13. Angelini, G; Ketzler, JT; Coursin, DB
    Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit
    CRITICAL CARE CLINICS
    
    G. Angelini et al., "Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit", CRIT CARE C, 17(4), 2001, pp. 863
14. Burns, MJ
    The pharmacology and toxicology of atypical antipsychotic agents
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
    
    M.J. Burns, "The pharmacology and toxicology of atypical antipsychotic agents", J TOX-CLIN, 39(1), 2001, pp. 1-14
15. Biancosino, B; Zanchi, P; Agostini, M; Grassi, L
    Suspected neuroleptic catatonia induced by clozapine
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    B. Biancosino et al., "Suspected neuroleptic catatonia induced by clozapine", CAN J PSY, 46(5), 2001, pp. 458-458
16. Kubo, S; Orihara, Y; Kitamura, O; Ikematsu, K; Tsuda, R; Nakasono, I
    An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria
    FORENSIC SCIENCE INTERNATIONAL
    
    S. Kubo et al., "An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria", FOREN SCI I, 115(1-2), 2001, pp. 155-158
17. Valevski, A; Loebl, T; Keren, T; Bodinger, L; Weizman, A
    Response of catatonia to risperidone: Two case reports
    CLINICAL NEUROPHARMACOLOGY
    
    A. Valevski et al., "Response of catatonia to risperidone: Two case reports", CLIN NEUROP, 24(4), 2001, pp. 228-231
18. Fink, M
    Catatonia: syndrome or schizophrenia subtype? Recognition and treatment
    JOURNAL OF NEURAL TRANSMISSION
    
    M. Fink, "Catatonia: syndrome or schizophrenia subtype? Recognition and treatment", J NEURAL TR, 108(6), 2001, pp. 637-644
19. Teter, CJ; Guthrie, SK
    A comprehensive review of MDMA and GHB: Two common club drugs
    PHARMACOTHERAPY
    
    C.J. Teter e S.K. Guthrie, "A comprehensive review of MDMA and GHB: Two common club drugs", PHARMACOTHE, 21(12), 2001, pp. 1486-1513
20. Sethi, KD
    Movement disorders induced by dopamine blocking agents
    SEMINARS IN NEUROLOGY
    
    K.D. Sethi, "Movement disorders induced by dopamine blocking agents", SEM NEUROL, 21(1), 2001, pp. 59-68
21. Turner, MR; Gainsborough, N
    Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen
    JOURNAL OF PSYCHOPHARMACOLOGY
    
    M.R. Turner e N. Gainsborough, "Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen", J PSYCHOPH, 15(1), 2001, pp. 61-63
22. Wappler, F
    Malignant hyperthermia
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY
    
    F. Wappler, "Malignant hyperthermia", EUR J ANAES, 18(10), 2001, pp. 632-652
23. Sagrista-Sauleda, J; Romero-Ferrer, B; Moya, A; Permanyer-Miralda, G; Soler-Soler, J
    Variations in diagnostic yield of head-up tilt test and electrophysiology in groups of patients with syncope of unknown origin
    EUROPEAN HEART JOURNAL
    
    J. Sagrista-Sauleda et al., "Variations in diagnostic yield of head-up tilt test and electrophysiology in groups of patients with syncope of unknown origin", EUR HEART J, 22(10), 2001, pp. 857-865
24. Garcia-Anaya, M; Apiquian, R; Fresan, A
    Atypical anti-psychotics: review article.
    SALUD MENTAL
    
    M. Garcia-Anaya et al., "Atypical anti-psychotics: review article.", SALUD MENT, 24(5), 2001, pp. 37-43
25. Rhoney, DH; Parker, D
    Use of sedative and analgesic agents in neurotrauma patients: Effects on cerebral physiology
    NEUROLOGICAL RESEARCH
    
    D.H. Rhoney e D. Parker, "Use of sedative and analgesic agents in neurotrauma patients: Effects on cerebral physiology", NEUROL RES, 23(2-3), 2001, pp. 237-259
26. Hodge, CH; Jewell, M; Gummin, DD; Leikin, JB
    Atypical presentation of risperidone toxicity
    VETERINARY AND HUMAN TOXICOLOGY
    
    C.H. Hodge et al., "Atypical presentation of risperidone toxicity", VET HUM TOX, 43(6), 2001, pp. 339-341
27. Gracious, BL; Findling, RL
    Antipsychotic medications for children and adolescents
    PEDIATRIC ANNALS
    
    B.L. Gracious e R.L. Findling, "Antipsychotic medications for children and adolescents", PEDIAT ANN, 30(3), 2001, pp. 138
28. Susman, VL
    Clinical management of neuroleptic malignant syndrome
    PSYCHIATRIC QUARTERLY
    
    V.L. Susman, "Clinical management of neuroleptic malignant syndrome", PSYCHIAT Q, 72(4), 2001, pp. 325-336
29. Libenson, MH; Lev, MH; Yang, JM; Mark, EJ
    A 16-year-old boy with an altered mental status and muscle rigidity. Strychnine poisoning. Bipolar disease.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    M.H. Libenson et al., "A 16-year-old boy with an altered mental status and muscle rigidity. Strychnine poisoning. Bipolar disease.", N ENG J MED, 344(16), 2001, pp. 1232-1239
30. Frey, R; Schreinzer, D; Heiden, A; Kasper, S
    Electroconvulsive therapie
    NERVENARZT
    
    R. Frey et al., "Electroconvulsive therapie", NERVENARZT, 72(9), 2001, pp. 661-676
31. Ueda, M; Hamamoto, M; Nagayama, H; Okubo, S; Amemiya, S; Katayama, Y
    Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    
    M. Ueda et al., "Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome", J NE NE PSY, 71(1), 2001, pp. 111-113
32. Goff, ML
    Protecting our mentally ill: A critique of the role of Indiana state courts in protecting involuntarily committed mental patients' right to refuse medication
    INDIANA LAW JOURNAL
    
    M.L. Goff, "Protecting our mentally ill: A critique of the role of Indiana state courts in protecting involuntarily committed mental patients' right to refuse medication", INDIANA LAW, 76(4), 2001, pp. 983-999
33. Velickovic, M; Benabou, R; Brin, MF
    Cervical dystonia - Pathophysiology and treatment options
    DRUGS
    
    M. Velickovic et al., "Cervical dystonia - Pathophysiology and treatment options", DRUGS, 61(13), 2001, pp. 1921-1943
34. Bhana, N; Foster, RH; Olney, R; Plosker, GL
    Olanzapine - An updated review of its use in the management of schizophrenia
    DRUGS
    
    N. Bhana et al., "Olanzapine - An updated review of its use in the management of schizophrenia", DRUGS, 61(1), 2001, pp. 111-161
35. Ansell, SM; Pitot, HC; Burch, PA; Kvols, LK; Mahoney, MR; Rubin, J
    A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors
    CANCER
    
    S.M. Ansell et al., "A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors", CANCER, 91(8), 2001, pp. 1543-1548
36. Nisijima, K; Yoshino, T; Yui, K; Katoh, S
    Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome
    BRAIN RESEARCH
    
    K. Nisijima et al., "Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome", BRAIN RES, 890(1), 2001, pp. 23-31
37. Walter, S; Rey, JM; Dekker, F
    The humble case report
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    S. Walter et al., "The humble case report", AUST NZ J P, 35(2), 2001, pp. 240-245
38. Thorley, RR; Wertsch, JJ; Klingbeil, GE
    Acute hypothalamic instability in traumatic brain injury: A case report
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    
    R.R. Thorley et al., "Acute hypothalamic instability in traumatic brain injury: A case report", ARCH PHYS M, 82(2), 2001, pp. 246-249
39. Tanvetyanon, T; Dissin, J; Selcer, UM
    Hyperthermia and chronic pancerebellar syndrome after cocaine abuse
    ARCHIVES OF INTERNAL MEDICINE
    
    T. Tanvetyanon et al., "Hyperthermia and chronic pancerebellar syndrome after cocaine abuse", ARCH IN MED, 161(4), 2001, pp. 608-610
40. Gerbershagen, MU; Ito, WD; Wappler, F; Fiege, M; Esch, JSA
    Neuroleptic malignant syndrome after haloperidol application
    ANAESTHESIST
    
    M.U. Gerbershagen et al., "Neuroleptic malignant syndrome after haloperidol application", ANAESTHESIS, 50(5), 2001, pp. 329-332
41. Hoff, M; Kramp, B
    Neuroendocrine tumor of the larynx (NETL) - An uncommon differential diagnosis.
    LARYNGO-RHINO-OTOLOGIE
    
    M. Hoff e B. Kramp, "Neuroendocrine tumor of the larynx (NETL) - An uncommon differential diagnosis.", LARY RH OTO, 79(10), 2000, pp. 573-578
42. Onofrj, M; Thomas, A; Bonanni, L; Iacono, D; Gambi, F
    Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine
    NEUROLOGICAL SCIENCES
    
    M. Onofrj et al., "Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine", NEUROL SCI, 21(4), 2000, pp. 209-215
43. Marenco, J; Naimi, S; Hijazi, Z; Patel, A; Pandian, N
    Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    J. Marenco et al., "Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting", CATHET C IN, 51(2), 2000, pp. 210-213
44. Bhana, N; Spencer, CM
    Risperidone - A review of its use in the management of the behavioural andpsychological symptoms of dementia
    DRUGS & AGING
    
    N. Bhana e C.M. Spencer, "Risperidone - A review of its use in the management of the behavioural andpsychological symptoms of dementia", DRUG AGING, 16(6), 2000, pp. 451-471
45. Oberg, K
    State of the art and future prospects in the management of neuroendocrine tumors
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    
    K. Oberg, "State of the art and future prospects in the management of neuroendocrine tumors", Q J NUCL M, 44(1), 2000, pp. 3-12
46. McDonald, WM; Greenberg, BD
    Electroconvulsive therapy in the treatment of neuropsychiatric conditions and transcranial magnetic stimulation as a pathophysiological probe in neuropsychiatry
    DEPRESSION AND ANXIETY
    
    W.M. McDonald e B.D. Greenberg, "Electroconvulsive therapy in the treatment of neuropsychiatric conditions and transcranial magnetic stimulation as a pathophysiological probe in neuropsychiatry", DEPRESS ANX, 12(3), 2000, pp. 135-143
47. Worrel, JA; Marken, PA; Beckman, SE; Ruehter, VL
    Atypical antipsychotic agents: A critical review
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    J.A. Worrel et al., "Atypical antipsychotic agents: A critical review", AM J HEAL S, 57(3), 2000, pp. 238-255
48. Elliott, ESR; Marken, PA; Ruehter, VL
    Clozapine-associated extrapyramidal reaction
    ANNALS OF PHARMACOTHERAPY
    
    E.S.R. Elliott et al., "Clozapine-associated extrapyramidal reaction", ANN PHARMAC, 34(5), 2000, pp. 615-618
49. Gregorakos, L; Thomaides, T; Stratouli, S; Sakayanni, E
    The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome
    CLINICAL AUTONOMIC RESEARCH
    
    L. Gregorakos et al., "The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome", CLIN AUTON, 10(4), 2000, pp. 193-196
50. Henderson, MJ; Mellers, JDC
    Psychosis in Parkinson's disease: 'between a rock and a hard place'
    INTERNATIONAL REVIEW OF PSYCHIATRY
    
    M.J. Henderson e J.D.C. Mellers, "Psychosis in Parkinson's disease: 'between a rock and a hard place'", INT R PSYC, 12(4), 2000, pp. 319-334
51. Wirshing, DA; Erhart, SM; Pierre, JM; Boyd, JA
    Nonextrapyramidal side effects of novel antipsychotics
    CURRENT OPINION IN PSYCHIATRY
    
    D.A. Wirshing et al., "Nonextrapyramidal side effects of novel antipsychotics", CUR OPIN P, 13(1), 2000, pp. 45-50
52. Mazzocato, C; Stiefel, F; Buclin, T; Berney, A
    Psychopharmacology in supportive care of cancer: a review for the clinician - II. Neuroleptics
    SUPPORTIVE CARE IN CANCER
    
    C. Mazzocato et al., "Psychopharmacology in supportive care of cancer: a review for the clinician - II. Neuroleptics", SUPP CARE C, 8(2), 2000, pp. 89-97
53. Spivak, B; Maline, DI; Kozyrev, VN; Mester, R; Neduva, SA; Ravilov, RS; Weizman, A
    Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow
    EUROPEAN PSYCHIATRY
    
    B. Spivak et al., "Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow", EUR PSYCHIA, 15(5), 2000, pp. 330-333
54. Kunishima, Y; Masumori, N; Kadono, M; Tsukamoto, T
    A case of neuroleptic malignant syndrome in a patient with hemodialysis
    INTERNATIONAL JOURNAL OF UROLOGY
    
    Y. Kunishima et al., "A case of neuroleptic malignant syndrome in a patient with hemodialysis", INT J UROL, 7(2), 2000, pp. 62-64
55. Nemets, B; Geller, V; Grisaru, N; Belmaker, RH
    Olanzapine treatment of clozapine-induced NMS
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    B. Nemets et al., "Olanzapine treatment of clozapine-induced NMS", HUM PSYCHOP, 15(2), 2000, pp. 77-78
56. Stanfield, SC; Privette, T
    Neuroleptic malignant syndrome associated with olanzapine therapy: A case report
    JOURNAL OF EMERGENCY MEDICINE
    
    S.C. Stanfield e T. Privette, "Neuroleptic malignant syndrome associated with olanzapine therapy: A case report", J EMERG MED, 19(4), 2000, pp. 355-357
57. David, WS
    Myoglobinuria
    NEUROLOGIC CLINICS
    
    W.S. David, "Myoglobinuria", NEUROL CLIN, 18(1), 2000, pp. 215
58. Chong, SA; Remington, G
    Clozapine augmentation: Safety and efficacy
    SCHIZOPHRENIA BULLETIN
    
    S.A. Chong e G. Remington, "Clozapine augmentation: Safety and efficacy", SCHIZO BULL, 26(2), 2000, pp. 421-440
59. Yoshikawa, H; Watanabe, T; Abe, T; Oda, Y; Ozawa, K
    Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child
    BRAIN & DEVELOPMENT
    
    H. Yoshikawa et al., "Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child", BRAIN DEVEL, 22(4), 2000, pp. 256-258
60. Radomski, JW; Dursun, SM; Reveley, MA; Kutcher, SP
    An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria
    MEDICAL HYPOTHESES
    
    J.W. Radomski et al., "An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria", MED HYPOTH, 55(3), 2000, pp. 218-224
61. Green, B
    Focus on risperidone
    CURRENT MEDICAL RESEARCH AND OPINION
    
    B. Green, "Focus on risperidone", CURR MED R, 16(2), 2000, pp. 57-65
62. Todd, JF; Meeran, K
    The tumour vanishes
    CLINICAL ENDOCRINOLOGY
    
    J.F. Todd e K. Meeran, "The tumour vanishes", CLIN ENDOCR, 53(6), 2000, pp. 663-664
63. Sechi, G; Agnetti, V; Masuri, R; Deiana, GA; Pugliatti, M; Paulus, KSM; Rosati, G
    Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    G. Sechi et al., "Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies", PROG NEUR-P, 24(6), 2000, pp. 1043-1051
64. Nisijima, K
    Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    K. Nisijima, "Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome", J CL PSYCH, 20(1), 2000, pp. 107-108
65. O'Halloran, RL; Frank, JG
    Asphyxial death during prone restraint revisited - A report of 21 cases
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY
    
    R.L. O'Halloran e J.G. Frank, "Asphyxial death during prone restraint revisited - A report of 21 cases", AM J FOREN, 21(1), 2000, pp. 39-52
66. Otani, K; Aoshima, T
    Pharmacogenetics of classical and new antipsychotic drugs
    THERAPEUTIC DRUG MONITORING
    
    K. Otani e T. Aoshima, "Pharmacogenetics of classical and new antipsychotic drugs", THER DRUG M, 22(1), 2000, pp. 118-121
67. Vlay, SC; Brodsky, C; Vlay, LC
    Safety and tolerability of an aggressive tilt table test protocol in the evaluation of patients with suspected neurocardiogenic syncope
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    S.C. Vlay et al., "Safety and tolerability of an aggressive tilt table test protocol in the evaluation of patients with suspected neurocardiogenic syncope", PACE, 23(4), 2000, pp. 441-445
68. Cook, JD; Caplan, YH; LoDico, CP; Bush, DM
    The characterization of human urine for specimen validity determination inworkplace drug testing: A review
    JOURNAL OF ANALYTICAL TOXICOLOGY
    
    J.D. Cook et al., "The characterization of human urine for specimen validity determination inworkplace drug testing: A review", J ANAL TOX, 24(7), 2000, pp. 579-588
69. Dev, V; Raniwalla, J
    Quetiapine - A review of its safety in the management of schizophrenia
    DRUG SAFETY
    
    V. Dev e J. Raniwalla, "Quetiapine - A review of its safety in the management of schizophrenia", DRUG SAFETY, 23(4), 2000, pp. 295-307
70. Stanniland, C; Taylor, D
    Tolerability of atypical antipsychotics
    DRUG SAFETY
    
    C. Stanniland e D. Taylor, "Tolerability of atypical antipsychotics", DRUG SAFETY, 22(3), 2000, pp. 195-214
71. Noel, F; Geurts, M; Maloteaux, JM
    Selective destruction of nigrostriatal dopaminergic neurons does not alter[H-3]-ryanodine binding in rat striatum
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    F. Noel et al., "Selective destruction of nigrostriatal dopaminergic neurons does not alter[H-3]-ryanodine binding in rat striatum", BRAZ J MED, 33(2), 2000, pp. 237-240
72. Keck, PE; Arnold, LM
    The serotonin syndrome
    PSYCHIATRIC ANNALS
    
    P.E. Keck e L.M. Arnold, "The serotonin syndrome", PSYCHIAT AN, 30(5), 2000, pp. 333-343
73. Jenkins, DH
    Substance abuse and withdrawn in the intensive care unit - Contemporary issues
    SURGICAL CLINICS OF NORTH AMERICA
    
    D.H. Jenkins, "Substance abuse and withdrawn in the intensive care unit - Contemporary issues", SURG CL NA, 80(3), 2000, pp. 1033
74. Calvo-Romero, JM; Bonilla-Gracia, MD; Ramos-Salado, JL; Bureo-Dacal, P
    Rigidity, hyperthermia, and altered mental status
    POSTGRADUATE MEDICAL JOURNAL
    
    J.M. Calvo-Romero et al., "Rigidity, hyperthermia, and altered mental status", POSTG MED J, 76(901), 2000, pp. 717
75. Spunt, SL; Pratt, CB; Rao, BN; Pritchard, M; Jenkins, JJ; Hill, DA; Cain, AM; Pappo, AS
    Childhood carcinoid tumors: The St Jude Children's Research Hospital experience
    JOURNAL OF PEDIATRIC SURGERY
    
    S.L. Spunt et al., "Childhood carcinoid tumors: The St Jude Children's Research Hospital experience", J PED SURG, 35(9), 2000, pp. 1282-1286
76. Behan, WMH; Madigan, M; Clark, BJ; Goldberg, J; McLellan, DR
    Muscle changes in the neuroleptic malignant syndrome
    JOURNAL OF CLINICAL PATHOLOGY
    
    W.M.H. Behan et al., "Muscle changes in the neuroleptic malignant syndrome", J CLIN PATH, 53(3), 2000, pp. 223-227
77. Pierantozzi, M; Sabato, AF; Leonardis, F; Marciani, MG; Cicardi, C; Giacomini, P; Bernardi, G; Stanzione, P
    Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes
    EXPERIMENTAL BRAIN RESEARCH
    
    M. Pierantozzi et al., "Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes", EXP BRAIN R, 133(3), 2000, pp. 368-376
78. Fujikawa, TG; Itabashi, HH; Wu, AG; Shinmei, SS
    Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy
    EPILEPSIA
    
    T.G. Fujikawa et al., "Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy", EPILEPSIA, 41(8), 2000, pp. 981-991
79. Arnold, R; Simon, B; Wied, M
    Treatment of neuroendocrine GEP tumours with somatostatin analogues - A review
    DIGESTION
    
    R. Arnold et al., "Treatment of neuroendocrine GEP tumours with somatostatin analogues - A review", DIGESTION, 62, 2000, pp. 84-91
80. Malur, C; Fink, M; Francis, A
    Can delirium relieve psychosis?
    COMPREHENSIVE PSYCHIATRY
    
    C. Malur et al., "Can delirium relieve psychosis?", COMP PSYCHI, 41(6), 2000, pp. 450-453
81. Cavagna, D; Zorzato, F; Babini, E; Prestipino, G; Treves, S
    Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca2+ release channel
    BRITISH JOURNAL OF PHARMACOLOGY
    
    D. Cavagna et al., "Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca2+ release channel", BR J PHARM, 131(2), 2000, pp. 335-341
82. Esler, MD; Pratt, ME; Brunner, MD
    Postoperative orphenadrine withdrawal
    BRITISH JOURNAL OF ANAESTHESIA
    
    M.D. Esler et al., "Postoperative orphenadrine withdrawal", BR J ANAEST, 85(3), 2000, pp. 497-497
83. 
    PART A: Background information and treatment recommendations for patients with HIV/AIDS - Introduction
    AMERICAN JOURNAL OF PSYCHIATRY
    
    AM J PSYCHI, 157(11), 2000, pp. 1-62
84. Ducreux, M; Ruszniewski, P; Chayvialle, JA; Blumberg, J; Cloarec, D; Michel, H; Raymond, JM; Dupas, JL; Gouerou, H; Jian, R; Genestin, E; Hammel, P; Rougier, P
    The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    M. Ducreux et al., "The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors", AM J GASTRO, 95(11), 2000, pp. 3276-3281
85. Spivak, B; Maline, DI; Vered, Y; Kozyrev, VN; Mester, R; Neduva, SA; Ravilov, RS; Graff, E; Weizman, A
    Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome
    ACTA PSYCHIATRICA SCANDINAVICA
    
    B. Spivak et al., "Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome", ACT PSYC SC, 102(3), 2000, pp. 226-230
86. Jarventausta, K; Leinonen, E
    Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment
    ACTA PSYCHIATRICA SCANDINAVICA
    
    K. Jarventausta e E. Leinonen, "Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment", ACT PSYC SC, 102(3), 2000, pp. 231-233
87. Bartenstein, P; Grunwald, F; Kuwert, T; Tatsch, K; Sabri, O; Benkert, O; Fahlbusch, R; Grunder, G; Herholz, K; Weiller, C
    Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma
    NUKLEARMEDIZIN-NUCLEAR MEDICINE
    
    P. Bartenstein et al., "Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma", NUKLEARMED, 39(8), 2000, pp. 218-232
88. Leber, K; Malek, A; D'Agostino, A; Adelman, HM
    A veteran with acute mental changes years after combat
    HOSPITAL PRACTICE
    
    K. Leber et al., "A veteran with acute mental changes years after combat", HOSP PRACT, 34(6), 1999, pp. 21-22
89. Clark, T; Rickards, H
    Catatonia 2: diagnosis, management and prognosis
    HOSPITAL MEDICINE
    
    T. Clark e H. Rickards, "Catatonia 2: diagnosis, management and prognosis", HOSP MED, 60(11), 1999, pp. 812-814
90. Huang, TL; Ree, SC; Huang, YC; Liu, HY; Yang, YY
    Catatonic features: Differential diagnosis and treatments at an emergency unit
    PSYCHIATRY AND CLINICAL NEUROSCIENCES
    
    T.L. Huang et al., "Catatonic features: Differential diagnosis and treatments at an emergency unit", PSY CLIN N, 53(1), 1999, pp. 63-66
91. Kusumi, I; Koyama, T
    Algorithms for the treatment of acute side effects induced by neuroleptics
    PSYCHIATRY AND CLINICAL NEUROSCIENCES
    
    I. Kusumi e T. Koyama, "Algorithms for the treatment of acute side effects induced by neuroleptics", PSY CLIN N, 53, 1999, pp. S19-S22
92. Oyewumi, LK; McKnight, M; Cernovsky, ZZ
    Lithium dosage and leukocyte counts in psychiatric patients
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    
    L.K. Oyewumi et al., "Lithium dosage and leukocyte counts in psychiatric patients", J PSYCH NEU, 24(3), 1999, pp. 215-221
93. Szabadi, E; Tavernor, S
    Hypo- and hypersalivation induced by psychoactive drugs - Incidence, mechanisms and therapeutic implications
    CNS DRUGS
    
    E. Szabadi e S. Tavernor, "Hypo- and hypersalivation induced by psychoactive drugs - Incidence, mechanisms and therapeutic implications", CNS DRUGS, 11(6), 1999, pp. 449-466
94. Fink, M
    ECT in delirious states
    JOURNAL OF ECT
    
    M. Fink, "ECT in delirious states", J ECT, 15(3), 1999, pp. 175-177
95. Nisijima, K; Ishiguro, T
    Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: A report of five cases
    JOURNAL OF ECT
    
    K. Nisijima e T. Ishiguro, "Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: A report of five cases", J ECT, 15(2), 1999, pp. 158-163
96. Horwath, E; Cournos, F
    NMS and HIV
    PSYCHIATRIC SERVICES
    
    E. Horwath e F. Cournos, "NMS and HIV", PSYCH SERV, 50(4), 1999, pp. 564-564
97. Marcus, EL; Vass, A; Zislin, J
    Marked elevation of serum creatine kinase associated with olanzapine therapy
    ANNALS OF PHARMACOTHERAPY
    
    E.L. Marcus et al., "Marked elevation of serum creatine kinase associated with olanzapine therapy", ANN PHARMAC, 33(6), 1999, pp. 697-700
98. Karagianis, JL; Phillips, LC; Hogan, KP; LeDrew, KK
    Clozapine-associated neuroleptic malignant syndrome: Two new cases and a review of the literature
    ANNALS OF PHARMACOTHERAPY
    
    J.L. Karagianis et al., "Clozapine-associated neuroleptic malignant syndrome: Two new cases and a review of the literature", ANN PHARMAC, 33(5), 1999, pp. 623-630
99. Brown, CS; Markowitz, JS; Moore, TR; Parker, NG
    Atypical antipsychotics: Part II - Adverse effects, drug interactions, andcosts
    ANNALS OF PHARMACOTHERAPY
    
    C.S. Brown et al., "Atypical antipsychotics: Part II - Adverse effects, drug interactions, andcosts", ANN PHARMAC, 33(2), 1999, pp. 210-217
100. Lin, TJ; Hung, DZ; Hu, WH; Yang, DY; Wu, TC
     Acute basagran (TM) poisoning mimicking neuroleptic malignant syndrome
     HUMAN & EXPERIMENTAL TOXICOLOGY
     
     T.J. Lin et al., "Acute basagran (TM) poisoning mimicking neuroleptic malignant syndrome", HUM EXP TOX, 18(8), 1999, pp. 493-494